{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T23:02:46Z","timestamp":1787353366691,"version":"build-2736575974"},"reference-count":7,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30EY014801"],"award-info":[{"award-number":["P30EY014801"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004328","name":"Genentech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004328","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology Retina"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.oret.2019.09.008","type":"journal-article","created":{"date-parts":[[2019,9,21]],"date-time":"2019-09-21T10:56:28Z","timestamp":1569063388000},"page":"226-228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Anti\u2013Vascular Endothelial Growth Factor Therapy for Choroidal Rupture-Associated Choroidal Neovascularization"],"prefix":"10.1016","volume":"4","author":[{"given":"Jonathan F.","family":"Russell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Albini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audina M.","family":"Berrocal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander R.","family":"Dubovy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Rosenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Smiddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayanth","family":"Sridhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin H.","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Harry W.","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.oret.2019.09.008_bib1","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1038\/eye.2008.370","article-title":"Choroidal neovascular membrane complicating traumatic choroidal rupture managed by intravitreal bevacizumab","volume":"23","author":"Yadav","year":"2009","journal-title":"Eye"},{"key":"10.1016\/j.oret.2019.09.008_bib2","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1007\/s00417-009-1098-2","article-title":"Intravitreal ranibizumab for choroidal neovascularization related to traumatic Bruch\u2019s membrane rupture","volume":"247","author":"Liang","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.oret.2019.09.008_bib3","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/ICB.0b013e31815e9903","article-title":"Intravitreal bevacizumab in the treatment of choroidal neovascularization from a traumatic choroidal rupture in a 9-year-old child","volume":"3","author":"Prasad","year":"2009","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.oret.2019.09.008_bib4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00006982-199818010-00011","article-title":"Morphometric characteristics of traumatic choroidal ruptures associated with neovascularization","volume":"18","author":"Secretan","year":"1998","journal-title":"Retina"},{"key":"10.1016\/j.oret.2019.09.008_bib5","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archopht.124.7.957","article-title":"Predictors of visual outcome and choroidal neovascular membrane formation after traumatic choroidal rupture","volume":"124","author":"Ament","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.oret.2019.09.008_bib6","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S0008-4182(04)80123-6","article-title":"Visual prognosis in patients with traumatic choroidal rupture","volume":"39","author":"Raman","year":"2004","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.oret.2019.09.008_bib7","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N\u00a0Engl J Med"}],"container-title":["Ophthalmology Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653019305603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468653019305603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:27:26Z","timestamp":1762853246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468653019305603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S2468653019305603"],"URL":"https:\/\/doi.org\/10.1016\/j.oret.2019.09.008","relation":{},"ISSN":["2468-6530"],"issn-type":[{"value":"2468-6530","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti\u2013Vascular Endothelial Growth Factor Therapy for Choroidal Rupture-Associated Choroidal Neovascularization","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology Retina","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oret.2019.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}